FGFR Gene Amplification clinical trials at UCSF
1 research study open to eligible people
FGFR gene amplification is when a cell has extra FGFR genes. UCSF is studying a medicine for liver and other solid tumors with FGFR changes. UCSF is checking safety and early tumor response in people with these changes.
Showing trials for
Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
open to eligible people ages 18 years and up
A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers with FGF/FGFR pathway aberrations, including locally advanced/metastatic hepatocellular carcinoma and other advanced solid tumors.
San Francisco, California and other locations
Last updated: